86. 20260605_A New Study of Pancreatic Cancer

[miaaa]

A new study has found that a pill called daraxonrasib is helping people with advanced pancreatic cancer live longer. Researchers at the University of California, Los Angeles, say the drug blocks a mutated protein that fuels tumor growth in more than 90 percent of pancreatic cancer cases. Dr. Zev Wainberg, who led the study, says the daily pills nearly double survival time, a median of 13.2months, and with fewer side effects compared to additional chemotherapy. The findings are in The New England Journal of Medicine and were presented Sunday at the American Society for Clinical Oncology meeting in Chicago.

* pancreatic 췌장의

  mutate 돌연변이를 만들다

  fuel 촉진하다

  median  중앙값; 중간의

  chemotherapy 화학 요법

  clinical 임상의

  oncology 종양학